Gilead Sciences (GILD) Net Income Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
168.07% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-52.40% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-45.93% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-182.77% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
5.14% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
53.69% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
- |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
8.81% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
53.69% |
| Dec 31, 2025 |
41.86% |
| Sep 30, 2025 |
143.58% |
| Jun 30, 2025 |
21.42% |
| Mar 31, 2025 |
131.53% |
| Dec 31, 2024 |
25.85% |
| Sep 30, 2024 |
-42.31% |
| Jun 30, 2024 |
55.44% |
| Mar 31, 2024 |
-523.88% |
| Dec 31, 2023 |
-13.29% |
| Sep 30, 2023 |
21.61% |
| Jun 30, 2023 |
-8.46% |
| Mar 31, 2023 |
8,100.00% |
| Dec 31, 2022 |
334.31% |
| Sep 30, 2022 |
-30.94% |
| Jun 30, 2022 |
-25.18% |
| Mar 31, 2022 |
-99.30% |
| Dec 31, 2021 |
-75.65% |
| Sep 30, 2021 |
632.58% |
| Jun 30, 2021 |
145.34% |
| Mar 31, 2021 |
11.96% |
| Dec 31, 2020 |
120.26% |
| Sep 30, 2020 |
130.22% |
| Jun 30, 2020 |
-278.45% |
| Mar 31, 2020 |
-21.85% |
| Dec 31, 2019 |
63.79% |
| Sep 30, 2019 |
-155.65% |
| Jun 30, 2019 |
3.08% |
| Mar 31, 2019 |
27.88% |
| Dec 31, 2018 |
111.65% |
| Sep 30, 2018 |
-22.60% |
| Jun 30, 2018 |
-40.73% |
| Mar 31, 2018 |
-42.98% |
| Dec 31, 2017 |
-218.55% |
| Sep 30, 2017 |
-18.44% |
| Jun 30, 2017 |
-12.24% |
| Mar 31, 2017 |
-24.33% |
| Dec 31, 2016 |
-33.85% |
| Sep 30, 2016 |
-27.59% |
| Jun 30, 2016 |
-22.24% |
| Mar 31, 2016 |
-17.66% |
| Dec 31, 2015 |
35.33% |
| Sep 30, 2015 |
68.58% |
| Jun 30, 2015 |
23.21% |
| Mar 31, 2015 |
94.87% |
| Dec 31, 2014 |
340.20% |
| Sep 30, 2014 |
246.91% |
| Jun 30, 2014 |
375.50% |
| Mar 31, 2014 |
209.74% |
| Dec 31, 2013 |
3.57% |
| Sep 30, 2013 |
17.02% |
| Jun 30, 2013 |
8.72% |
| Mar 31, 2013 |
64.04% |
| Dec 31, 2012 |
14.75% |
| Sep 30, 2012 |
-9.02% |
| Jun 30, 2012 |
-4.90% |
| Mar 31, 2012 |
-32.41% |
| Dec 31, 2011 |
5.65% |
| Sep 30, 2011 |
5.04% |
| Jun 30, 2011 |
4.70% |
| Mar 31, 2011 |
-24.03% |
| Dec 31, 2010 |
-58.61% |
| Sep 30, 2010 |
4.73% |
| Jun 30, 2010 |
24.60% |
| Mar 31, 2010 |
45.27% |
